Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk Criteria.

Though limited samples restricted statistical testing, there was a clear trend toward increased sC5b‐9 levels at TA‐TMA diagnosis in patients who achieved a CR with eculizumab (median 971 vs. 343 ng/dL if≤PR) that should be further explored in the future.

also in 19,460 other papers